title: Specific epidermal growth factor receptor autophosphorylation sites promote mouse colon epithelial cell chemotaxis and restitution.
abstract: Upon ligand binding, epidermal growth factor (EGF) receptor (R) autophosphorylates on COOH-terminal tyrosines, generating docking sites for signaling partners that stimulate proliferation, restitution, and chemotaxis. Specificity for individual EGFR tyrosines in cellular responses has been hypothesized but not well documented. Here we tested the requirement for particular tyrosines, and associated downstream pathways, in mouse colon epithelial cell chemotactic migration. We compared these requirements to those for the phenotypically distinct restitution (wound healing) migration. Wild-type, Y992/1173F, Y1045F, Y1068F, and Y1086F EGFR constructs were expressed in EGFR(-/-) cells; EGF-induced chemotaxis or restitution were determined by Boyden chamber or modified scratch wound assay, respectively. Pharmacological inhibitors of p38, phospholipase C (PLC), Src, MEK, JNK/SAPK, phosphatidylinositol 3-kinase (PI 3-kinase), and protein kinase C (PKC) were used to block EGF-stimulated signaling. Pathway activation was determined by immunoblot analysis. Unlike wild-type EGFR, Y992/1173F and Y1086F EGFR did not stimulate colon epithelial cell chemotaxis toward EGF; Y1045F and Y1068F EGFR partially stimulated chemotaxis. Only wild-type EGFR promoted colonocyte restitution. Inhibition of p38, PLC, and Src, or Grb2 knockdown, blocked chemotaxis; JNK, PI 3-kinase, and PKC inhibitors or c-Cbl knockdown blocked restitution but not chemotaxis. All four EGFR mutants stimulated downstream signaling in response to EGF, but Y992/1173F EGFR was partially defective in PLCγ activation whereas both Y1068F and Y1086F EGFR failed to activate Src. We conclude that specific EGFR tyrosines play key roles in determining cellular responses to ligand. Chemotaxis and restitution, which have different migration phenotypes and physiological consequences, have overlapping but not identical EGFR signaling requirements.
authors: Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
authors: Toshimitsu
authors: T
authors: Yamaoka
authors: Mark R
authors: MR
authors: Frey
authors: Rebecca S
authors: RS
authors: Dise
authors: Jessica K
authors: JK
authors: Bernard
authors: D Brent
authors: DB
authors: Polk
references: EMBO J. 2000 Jul 3;19(13):3159-67
references: 10880430
references: Surgery. 1992 Aug;112(2):299-307; discussion 307-8
references: 1353641
references: Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):587-91
references: 7678459
references: J Biol Chem. 1990 Mar 5;265(7):3944-8
references: 1689311
references: Am J Respir Cell Mol Biol. 2004 Nov;31(5):528-37
references: 15256384
references: EMBO J. 1991 Aug;10(8):2077-86
references: 1676673
references: EMBO J. 2002 Feb 1;21(3):303-13
references: 11823423
references: Proc Natl Acad Sci U S A. 1987 Nov;84(22):7832-6
references: 3500470
references: Nature. 1984 Oct 4-10;311(5985):483-5
references: 6090945
references: Exp Cell Res. 2002 Jul 1;277(1):86-94
references: 12061819
references: Exp Cell Res. 2001 Feb 15;263(2):254-64
references: 11161724
references: J Cell Sci. 1998 Aug;111 ( Pt 16):2423-32
references: 9683636
references: J Biol Chem. 1999 Sep 10;274(37):26091-7
references: 10473558
references: J Biol Chem. 1992 Apr 25;267(12):8056-63
references: 1349015
references: Cell Motil Cytoskeleton. 1999 Dec;44(4):227-33
references: 10602252
references: FASEB J. 2005 Mar;19(3):428-30
references: 15746183
references: J Cell Sci. 1998 Mar;111 ( Pt 5):615-24
references: 9454735
references: Melanoma Res. 2005 Feb;15(1):21-8
references: 15714117
references: J Biol Chem. 1992 Apr 25;267(12):8672-8
references: 1314835
references: Mol Endocrinol. 1998 Apr;12(4):536-43
references: 9544989
references: Mol Cell Proteomics. 2008 Oct;7(10):1902-24
references: 18687633
references: Clin Cancer Res. 2009 Jan 1;15(1):100-9
references: 19118037
references: Am J Physiol. 1999 Dec;277(6):C1149-59
references: 10600766
references: Mol Cell Biol. 2000 Feb;20(4):1448-59
references: 10648629
references: Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4277-83
references: 15557433
references: Gastroenterology. 1998 Mar;114(3):493-502
references: 9496939
references: Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11772-7
references: 18701712
references: Mol Cell Biol. 1994 Aug;14(8):5192-201
references: 7518560
references: Science. 1995 Jul 14;269(5221):230-4
references: 7618084
references: J Cell Biol. 1994 Nov;127(3):847-57
references: 7962064
references: Arch Dermatol Res. 2009 Apr;301(4):307-17
references: 19330341
references: J Biol Chem. 1989 Jun 25;264(18):10667-71
references: 2543678
references: Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):167-71
references: 7506413
references: J Biol Chem. 1992 May 15;267(14):9678-83
references: 1315766
references: J Biol Chem. 1996 Nov 1;271(44):27456-61
references: 8910327
references: J Biol Chem. 2004 Oct 22;279(43):44513-21
references: 15316018
references: J Biol Chem. 1994 Apr 22;269(16):12320-4
references: 8163537
references: Science. 1993 May 21;260(5111):1086-94
references: 8493552
references: Exp Cell Res. 2005 Mar 10;304(1):305-16
references: 15707595
references: Cancer Res. 2001 Oct 1;61(19):7079-90
references: 11585739
references: Growth Factors. 2002 Jun;20(2):81-91
references: 12148566
references: Gastroenterology. 2005 Aug;129(2):609-25
references: 16083716
references: Curr Opin Chem Biol. 1997 Aug;1(2):227-34
references: 9667855
references: J Biol Chem. 2001 May 4;276(18):15554-60
references: 11279155
references: Mol Cell Biochem. 2005 Mar;271(1-2):29-41
references: 15881653
references: EMBO J. 2006 Dec 13;25(24):5683-92
references: 17139251